Beryl Drugs Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 5.09 Cr
- Company Age 31 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.19 Cr
- Satisfied Charges ₹ 6.64 Cr
- Revenue Growth 83.88%
- Profit Growth 216.25%
- Ebitda 376.65%
- Net Worth 10.60%
- Total Assets -1.75%
About Beryl Drugs
Beryl Drugs Limited (BDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 August 1993 and has a history of 31 years and seven months. Its registered office is in Indore, Madhya Pradesh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524606.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.09 Cr.
The company currently has active open charges totaling ₹8.19 Cr. The company has closed loans amounting to ₹6.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Beryl Drugs Limited India are Neha Sharma as COMPANY SECRETARY and Ashish Baraskar as Cfo. Sudhir Sethi, Sanjay Sethi, Abhinav Naik, and One other member serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L02423MP1993PLC007840
- Company No.
007840
- Stock Symbol
BSE : 524606
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Gwalior
Industry
Pharma
What products or services does Beryl Drugs Limited offer?
Beryl Drugs Limited offers a wide range of products and services, including Common Disease Medicines, IV Fluids, Chemical Reagents & Catalysts, Amine Compounds, Injectable Products, Batteries & Charge Storage Devices, Battery Raw Material, Kidney Drugs, Mannitol Injections, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Beryl Drugs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Sharma  | Company Secretary | 01-May-2014 | Current |
| Sanjay Sethi | Managing Director | 12-Dec-2000 | Current |
| Ashish Baraskar | CFO | 04-Sep-2014 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Sethi | Director | 12-Dec-2000 | Current |
| Abhinav Naik | Director | 30-May-2019 | Current |
| Shreya Saraf | Director | 30-May-2019 | Current |
Financial Performance of Beryl Drugs.
Beryl Drugs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 83.88% increase. The company also saw a substantial improvement in profitability, with a 216.25% increase in profit. The company's net worth Soared by an impressive increase of 10.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Beryl Drugs?
In 2023, Beryl Drugs had a promoter holding of 26.38% and a public holding of 73.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Narmada Extrusions LimitedShreya Saraf is a mutual person
Beryl Securities LimitedSudhir Sethi, Sanjay Sethi and 1 more are mutual person
Charges (Loans)
Open Charges
₹8.19 Cr
Satisfied Charges
₹6.64 Cr
Charges Breakdown by Lending Institutions
- Others : 8.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2024 | Others | ₹1.75 Cr | Open |
| 16 May 2024 | Others | ₹4.50 M | Open |
| 20 Mar 2023 | Others | ₹1.15 Cr | Open |
| 18 Mar 1997 | Others | ₹4.84 Cr | Open |
| 12 Jun 2020 | Others | ₹4.50 M | Satisfied |
How Many Employees Work at Beryl Drugs?
Beryl Drugs has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Beryl Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beryl Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Beryl Drugs
Recent activity within the organization
- Annual General Meeting
Beryl Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 1.75 Cr with Charge ID 100945463 was registered on 27 Jun 2024.
- Charges
A charge with Others amounted to Rs. 0.45 Cr with Charge ID 100930830 was registered on 16 May 2024.
- Balance Sheet
Beryl Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
- Charges
A charge with Others amounted to Rs. 1.15 Cr with Charge ID 100693923 was registered on 20 Mar 2023.
- Charges
A charge with Others of Rs. 4.84 Cr registered on 18 Mar 1997 with Charge ID 80050275 was modified on 06 Mar 2023.
Frequently asked questions
What is the Incorporation or founding date of Beryl Drugs Limited?
Beryl Drugs Limited was incorporated on 24 Aug 1993.
What is authorized share capital and paid-up capital of Beryl Drugs Limited?
The authorized share capital of Beryl Drugs Limited is ₹ 10.00 Cr and paid-up capital is ₹ 5.09 Cr.
Who are the current board members & directors of Beryl Drugs Limited?
Currently 6 directors are associated with Beryl Drugs Limited.
- Sudhir Sethi
- Sanjay Sethi
- Abhinav Naik
- Shreya Saraf
- Neha Sharma
- Ashish Baraskar
What is the registered address of Beryl Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Beryl Drugs Limited is 133 Kanchan Bagh India, Indore, Madhya Pradesh, 452001.
What is the corporate identification number (CIN) and company number of Beryl Drugs Limited?
The corporate identification number (CIN) of Beryl Drugs Limited is L02423MP1993PLC007840 and the company number is 007840 as per Ministry of Corporate Affairs (MCA).
Is Beryl Drugs Limited registered with any stock exchange in India?
Yes, Beryl Drugs Limited is registered on Bombay Stock Exchange (BSE).
What is the official website of Beryl Drugs Limited?
The Official website of Beryl Drugs Limited is https://www.beryldrugs.com
What has been the recent revenue trend for Beryl Drugs Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Beryl Drugs Limited has risen by 83.88%.
How many employees does Beryl Drugs Limited currently have?
As Per 2023 financial reports, 22 employees are currently employed by Beryl Drugs Limited.
What change has been observed in the net worth of Beryl Drugs Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Beryl Drugs Limited has experienced an upsurge of 10.60%.
What are the total open charges for Beryl Drugs Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Beryl Drugs Limited amount to ₹ 8.19 Cr.
When was the last Balance Sheet of Beryl Drugs Limited filed with the ROC?
The most recent Balance Sheet for Beryl Drugs Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
RK
Rajendra KumarDirectorSJ
Sunil JainDirectorHJ
Hemant JainDirectorAS
Avinash SharmaDirectorBJ
Bagachand JainDirectorBG
Bharti GurjarAdditional DirectorSS
Swarna SiyalDirectorYK
Yashesh KumarDirector